Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Nine new option listings and four option delistings on October 6th » 08:30
10/06/21
10/06
08:30
10/06/21
08:30
BCTX

BriaCell

$7.45 /

+0.01 (+0.13%)

, HLTH

Cue Health

$10.79 /

+0.735 (+7.31%)

, CRBU

Caribou Biosciences

$22.44 /

+0.29 (+1.31%)

, LPTX

Leap Therapeutics

$3.51 /

-0.08 (-2.23%)

, ARQQ

Arqit Quantum

$21.36 /

+0.5 (+2.40%)

, LVO

LiveOne

$3.07 /

+0.05 (+1.66%)

, FCUV

Focus Universal

$8.26 /

-0.04 (-0.48%)

, ZWS

Zurn Water Solutions

$33.04 /

-31.92 (-49.14%)

, VEI

Vine Energy

$17.75 /

+0.56 (+3.26%)

, LIVX

LiveXLive Media

/

+

, SBBP

Strongbridge Biopharma

$2.00 /

+0.03 (+1.52%)

New option listings for…

New option listings for October 6th include BriaCell Therapeutics Corporation (BCTX), HLTH Stock (HLTH), Caribou Biosciences Inc (CRBU), Leap Therapeutics (LPTX), Arqit Quantum Inc (ARQQ), LVO Stock (LVO), Focus Universal Inc (FCUV), ZWS Stock (ZWS), and Vine Energy Inc (Class A Stock) (VEI). Option delistings effective October 6th include Bitcoin-USD (BTCUSD), Ethereum-USD (ETHUSD), LiveXLive Media (LIVX), and Strongbridge Biopharma (SBBP).

ShowHide Related Items >><<
ZWS Zurn Water Solutions
$33.04 /

-31.92 (-49.14%)

VEI Vine Energy
$17.75 /

+0.56 (+3.26%)

SBBP Strongbridge Biopharma
$2.00 /

+0.03 (+1.52%)

LVO LiveOne
$3.07 /

+0.05 (+1.66%)

LPTX Leap Therapeutics
$3.51 /

-0.08 (-2.23%)

LIVX LiveXLive Media
/

+

FCUV Focus Universal
$8.26 /

-0.04 (-0.48%)

CRBU Caribou Biosciences
$22.44 /

+0.29 (+1.31%)

BCTX BriaCell
$7.45 /

+0.01 (+0.13%)

BCTX BriaCell
$7.45 /

+0.01 (+0.13%)

HLTH Cue Health
$10.79 /

+0.735 (+7.31%)

CRBU Caribou Biosciences
$22.44 /

+0.29 (+1.31%)

08/17/21
Fly Intel: Top five analyst initiations
08/17/21 SVB Leerink
SVB Leerink bullish on Caribou Biosciences, initiates with an Outperform
08/17/21 SVB Leerink
Caribou Biosciences initiated with an Outperform at SVB Leerink
08/17/21 BofA
BofA starts Caribou Biosciences at Buy with $30 price target
LPTX Leap Therapeutics
$3.51 /

-0.08 (-2.23%)

10/04/21 Mizuho
Leap Therapeutics initiated with a Buy at Mizuho
09/19/21 Piper Sandler
Piper Sandler keeps Overweight on Leap Therapeutics, ups target to $5
09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
ARQQ Arqit Quantum
$21.36 /

+0.5 (+2.40%)

LVO LiveOne
$3.07 /

+0.05 (+1.66%)

FCUV Focus Universal
$8.26 /

-0.04 (-0.48%)

ZWS Zurn Water Solutions
$33.04 /

-31.92 (-49.14%)

VEI Vine Energy
$17.75 /

+0.56 (+3.26%)

08/23/21
Fly Intel: Top five analyst downgrades
08/23/21 Morgan Stanley
Vine Energy downgraded to Equal Weight from Overweight at Morgan Stanley
04/12/21 Morgan Stanley
Vine Energy initiated with an Overweight at Morgan Stanley
04/12/21 Citi
Vine Energy initiated with a Buy at Citi
LIVX LiveXLive Media
/

+

06/29/21 Alliance Global Partners
LiveXLive price target raised to $11 at Alliance Global after guidance hike
06/29/21 H.C. Wainwright
LiveXLive Media price target raised to $7 from $6 at H.C. Wainwright
04/05/21 Alliance Global Partners
Tesla deliveries bullish for LiveXLive Media, says Alliance Global Partners
03/18/21 Alliance Global Partners
Alliance Global Partners reiterates Buy on LiveXLive Media, ups target to $10
SBBP Strongbridge Biopharma
$2.00 /

+0.03 (+1.52%)

05/25/21 Craig-Hallum
Strongbridge downgraded to Hold at Craig-Hallum on Xeris acquisition
05/25/21 Craig-Hallum
Strongbridge Biopharma downgraded to Hold from Buy at Craig-Hallum
05/25/21 Mizuho
Xeris Pharmaceuticals price target lowered to $9 from $14 at Mizuho
05/25/21 JMP Securities
Strongbridge downgraded to Market Perform from Outperform at JMP Securities
SBBP Strongbridge Biopharma
$2.00 /

+0.03 (+1.52%)

LPTX Leap Therapeutics
$3.51 /

-0.08 (-2.23%)

LIVX LiveXLive Media
/

+

  • 22
    Sep
  • 24
    Sep
  • 31
    Aug
  • 23
    Jul
  • 18
    Mar
  • 24
    Feb
VEI Vine Energy
$17.75 /

+0.56 (+3.26%)

SBBP Strongbridge Biopharma
$2.00 /

+0.03 (+1.52%)

LPTX Leap Therapeutics
$3.51 /

-0.08 (-2.23%)

HLTH Cue Health
$10.79 /

+0.735 (+7.31%)

CRBU Caribou Biosciences
$22.44 /

+0.29 (+1.31%)

LIVX LiveXLive Media
/

+

Initiation
Leap Therapeutics initiated with a Buy at Mizuho » 05:57
10/04/21
10/04
05:57
10/04/21
05:57
LPTX

Leap Therapeutics

$3.66 /

-0.345 (-8.63%)

Mizuho analyst Mara…

Mizuho analyst Mara Goldstein initiated coverage of Leap Therapeutics with a Buy rating and $6 price target. Recent data "serve as validation" for DKN-01, Goldstein tells investors in a research note. The analyst says early data from the commercially-relevant setting of front-line advanced gastric/ gastroesophageal junction brings DKN-01 "new visibility given the confirmation of DKK-1 as a biomarker and activity that appears independent of checkpoint status."

ShowHide Related Items >><<
LPTX Leap Therapeutics
$3.66 /

-0.345 (-8.63%)

LPTX Leap Therapeutics
$3.66 /

-0.345 (-8.63%)

09/19/21 Piper Sandler
Piper Sandler keeps Overweight on Leap Therapeutics, ups target to $5
09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
LPTX Leap Therapeutics
$3.66 /

-0.345 (-8.63%)

  • 22
    Sep
LPTX Leap Therapeutics
$3.66 /

-0.345 (-8.63%)

Over a month ago
Syndicate
Leap Therapeutics Spot Secondary priced at $2.85 » 08:45
09/22/21
09/22
08:45
09/22/21
08:45
LPTX

Leap Therapeutics

$3.41 /

+0.63 (+22.70%)

The offering was upsized…

The offering was upsized to $90M from $65M and priced at high end of $2.75-$2.85 marketed range. Piper Sandler, Raymond James and Mizuho are acting as joint book running managers for the offering.

ShowHide Related Items >><<
LPTX Leap Therapeutics
$3.41 /

+0.63 (+22.70%)

LPTX Leap Therapeutics
$3.41 /

+0.63 (+22.70%)

09/19/21 Piper Sandler
Piper Sandler keeps Overweight on Leap Therapeutics, ups target to $5
09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
LPTX Leap Therapeutics
$3.41 /

+0.63 (+22.70%)

  • 22
    Sep
LPTX Leap Therapeutics
$3.41 /

+0.63 (+22.70%)

On The Fly
Fly Intel: After-Hours Movers » 18:53
09/21/21
09/21
18:53
09/21/21
18:53
SFIX

Stitch Fix

$35.40 /

-0.995 (-2.73%)

, MRIN

Marin Software

$5.69 /

+0.585 (+11.47%)

, ALPN

Alpine Immune Sciences

$9.82 /

+0.21 (+2.19%)

, LAUR

Laureate Education

$17.18 /

-0.02 (-0.12%)

, BLUE

Bluebird Bio

$17.99 /

+0.06 (+0.33%)

, FDX

FedEx

$252.08 /

+1.26 (+0.50%)

, ADBE

Adobe

$646.30 /

+4.58 (+0.71%)

, SMMT

Summit Therapeutics

$6.46 /

+0.1 (+1.57%)

, LPTX

Leap Therapeutics

$3.41 /

+0.63 (+22.70%)

, GBNH

Greenbrook TMS

$9.43 /

+0.96 (+11.33%)

, XAIR

Beyond Air

$12.55 /

+0.82 (+6.99%)

, INCY

Incyte

$76.03 /

+0.12 (+0.16%)

, H

Hyatt

$73.69 /

-0.87 (-1.17%)

, SAFE

Safehold

$79.51 /

+0.01 (+0.01%)

Check out this evening's…

ShowHide Related Items >><<
XAIR Beyond Air
$12.55 /

+0.82 (+6.99%)

SMMT Summit Therapeutics
$6.46 /

+0.1 (+1.57%)

SFIX Stitch Fix
$35.40 /

-0.995 (-2.73%)

SAFE Safehold
$79.51 /

+0.01 (+0.01%)

MRIN Marin Software
$5.69 /

+0.585 (+11.47%)

LPTX Leap Therapeutics
$3.41 /

+0.63 (+22.70%)

LAUR Laureate Education
$17.18 /

-0.02 (-0.12%)

INCY Incyte
$76.03 /

+0.12 (+0.16%)

H Hyatt
$73.69 /

-0.87 (-1.17%)

GBNH Greenbrook TMS
$9.43 /

+0.96 (+11.33%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

BLUE Bluebird Bio
$17.99 /

+0.06 (+0.33%)

ALPN Alpine Immune Sciences
$9.82 /

+0.21 (+2.19%)

ADBE Adobe
$646.30 /

+4.58 (+0.71%)

SFIX Stitch Fix
$35.40 /

-0.995 (-2.73%)

09/15/21 MKM Partners
Stitch Fix price target lowered to $31 from $45 at MKM Partners
06/08/21 Canaccord
Stitch Fix price target raised to $76 from $68 at Canaccord
06/08/21 Truist
Stitch Fix price target raised to $77 from $60 at Truist
06/08/21 MKM Partners
Stitch Fix price target raised to $45 from $29 at MKM Partners
MRIN Marin Software
$5.69 /

+0.585 (+11.47%)

ALPN Alpine Immune Sciences
$9.82 /

+0.21 (+2.19%)

06/30/21 Piper Sandler
Piper reiterates Overweight rating on Alpine following Merck collaboration
12/21/20 H.C. Wainwright
Alpine Immune Sciences initiated with a Buy at H.C. Wainwright
LAUR Laureate Education
$17.18 /

-0.02 (-0.12%)

09/15/21 BMO Capital
Laureate Education resumed with an Outperform at BMO Capital
09/10/21 Morgan Stanley
Laureate Education resumed with an Overweight at Morgan Stanley
BLUE Bluebird Bio
$17.99 /

+0.06 (+0.33%)

08/10/21
Fly Intel: Top five analyst downgrades
08/10/21 BMO Capital
Bluebird Bio price target lowered to $21 from $29 at BMO Capital
08/10/21 Canaccord
Bluebird Bio downgraded to Hold from Buy at Canaccord
08/10/21 Mizuho
Bluebird Bio price target lowered to $29 from $70 at Mizuho
FDX FedEx
$252.08 /

+1.26 (+0.50%)

09/17/21 UBS
FedEx price target lowered to $380 from $397 at UBS
09/17/21 Baird
FedEx sentiment too negative with favorable outlook, says Baird
09/13/21 KeyBanc
FedEx price target lowered to $350 from $370 at KeyBanc
09/13/21 Citi
FedEx price target lowered to $360 from $365 at Citi
ADBE Adobe
$646.30 /

+4.58 (+0.71%)

09/20/21 Wells Fargo
Adobe initiated with an Overweight at Wells Fargo
09/20/21 Citi
Adobe shares may be pricing in front office tailwinds, says Citi
09/17/21 Mizuho
Adobe price target raised to $695 from $640 at Mizuho
09/16/21 BMO Capital
Adobe price target raised to $730 from $630 at BMO Capital
SMMT Summit Therapeutics
$6.46 /

+0.1 (+1.57%)

11/18/20 H.C. Wainwright
Summit Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
LPTX Leap Therapeutics
$3.41 /

+0.63 (+22.70%)

09/19/21 Piper Sandler
Piper Sandler keeps Overweight on Leap Therapeutics, ups target to $5
09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
GBNH Greenbrook TMS
$9.43 /

+0.96 (+11.33%)

07/08/21 Desjardins
Greenbrook TMS resumed with a Buy at Desjardins
XAIR Beyond Air
$12.55 /

+0.82 (+6.99%)

04/28/21
Fly Intel: Top five analyst initiations
04/28/21 Truist
Beyond Air initiated with a Buy at Truist
04/28/21 Truist
Beyond Air initiated with a Buy at Truist
INCY Incyte
$76.03 /

+0.12 (+0.16%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
09/01/21 Cowen
Odds of Incyte drug exclusion from class warning 'largely unchanged,' says Cowen
07/20/21 Benchmark
Incyte upgraded to Buy from Hold at Benchmark
H Hyatt
$73.69 /

-0.87 (-1.17%)

08/17/21
Fly Intel: Top five analyst upgrades
08/17/21 Truist
Hyatt upgraded to Hold from Sell at Truist
08/17/21 Truist
Hyatt upgraded to Hold from Sell at Truist
08/16/21 Stifel
Hyatt price target raised to $76.50 from $74 at Stifel
SAFE Safehold
$79.51 /

+0.01 (+0.01%)

09/21/21
Safehold files to sell 2M shares and concurrent private placement
07/30/21 Truist
Safehold price target raised to $80 from $72 at Truist
07/27/21 B. Riley
Safehold price target raised to $110 from $100 at B. Riley
07/22/21 Truist
Truist 'not overly concerned' by Safehold earnings miss
XAIR Beyond Air
$12.55 /

+0.82 (+6.99%)

SMMT Summit Therapeutics
$6.46 /

+0.1 (+1.57%)

SFIX Stitch Fix
$35.40 /

-0.995 (-2.73%)

SAFE Safehold
$79.51 /

+0.01 (+0.01%)

MRIN Marin Software
$5.69 /

+0.585 (+11.47%)

LPTX Leap Therapeutics
$3.41 /

+0.63 (+22.70%)

LAUR Laureate Education
$17.18 /

-0.02 (-0.12%)

INCY Incyte
$76.03 /

+0.12 (+0.16%)

H Hyatt
$73.69 /

-0.87 (-1.17%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

BLUE Bluebird Bio
$17.99 /

+0.06 (+0.33%)

ALPN Alpine Immune Sciences
$9.82 /

+0.21 (+2.19%)

ADBE Adobe
$646.30 /

+4.58 (+0.71%)

  • 22
    Sep
  • 23
    Sep
  • 22
    Sep
  • 23
    Sep
  • 11
    Nov
SFIX Stitch Fix
$35.40 /

-0.995 (-2.73%)

INCY Incyte
$76.03 /

+0.12 (+0.16%)

H Hyatt
$73.69 /

-0.87 (-1.17%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

ADBE Adobe
$646.30 /

+4.58 (+0.71%)

XAIR Beyond Air
$12.55 /

+0.82 (+6.99%)

SFIX Stitch Fix
$35.40 /

-0.995 (-2.73%)

SAFE Safehold
$79.51 /

+0.01 (+0.01%)

MRIN Marin Software
$5.69 /

+0.585 (+11.47%)

LPTX Leap Therapeutics
$3.41 /

+0.63 (+22.70%)

LAUR Laureate Education
$17.18 /

-0.02 (-0.12%)

INCY Incyte
$76.03 /

+0.12 (+0.16%)

H Hyatt
$73.69 /

-0.87 (-1.17%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

BLUE Bluebird Bio
$17.99 /

+0.06 (+0.33%)

ADBE Adobe
$646.30 /

+4.58 (+0.71%)

SFIX Stitch Fix
$35.40 /

-0.995 (-2.73%)

MRIN Marin Software
$5.69 /

+0.585 (+11.47%)

INCY Incyte
$76.03 /

+0.12 (+0.16%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

ADBE Adobe
$646.30 /

+4.58 (+0.71%)

Syndicate
Leap Therapeutics Spot Secondary; price range $2.75-$2.85 » 16:29
09/21/21
09/21
16:29
09/21/21
16:29
LPTX

Leap Therapeutics

$3.41 /

+0.63 (+22.70%)

Piper Sandler, Raymond…

Piper Sandler, Raymond James and Mizuho are acting as joint book running managers for the offering.

ShowHide Related Items >><<
LPTX Leap Therapeutics
$3.41 /

+0.63 (+22.70%)

LPTX Leap Therapeutics
$3.41 /

+0.63 (+22.70%)

09/19/21 Piper Sandler
Piper Sandler keeps Overweight on Leap Therapeutics, ups target to $5
09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
LPTX Leap Therapeutics
$3.41 /

+0.63 (+22.70%)

LPTX Leap Therapeutics
$3.41 /

+0.63 (+22.70%)

Syndicate
Leap Therapeutics files to sell common stock and pre-funded warrants » 16:02
09/21/21
09/21
16:02
09/21/21
16:02
LPTX

Leap Therapeutics

$3.43 /

+0.655 (+23.60%)

Leap Therapeutics…

Leap Therapeutics announced that it has commenced an underwritten public offering of its common stock and, in lieu of common stock, Leap intends to offer and sell to certain investors pre-funded warrants to purchase shares of its common stock. All shares of common stock and pre-funded warrants to be sold in the offering will be offered by Leap. Piper Sandler & Co., Raymond James & Associates, Inc. and Mizuho Securities USA LLC will act as book-running managers for the offering. Robert W. Baird & Co. Incorporated will act as lead manager for the offering.

ShowHide Related Items >><<
LPTX Leap Therapeutics
$3.43 /

+0.655 (+23.60%)

LPTX Leap Therapeutics
$3.43 /

+0.655 (+23.60%)

09/19/21 Piper Sandler
Piper Sandler keeps Overweight on Leap Therapeutics, ups target to $5
09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
LPTX Leap Therapeutics
$3.43 /

+0.655 (+23.60%)

LPTX Leap Therapeutics
$3.43 /

+0.655 (+23.60%)

Conference/Events
European Society for Medical Oncology to hold a virtual meeting » 04:55
09/21/21
09/21
04:55
09/21/21
04:55
ABBV

AbbVie

$106.42 /

-1.35 (-1.25%)

, AYLA

Ayala Pharmaceuticals

$12.00 /

-0.31 (-2.52%)

, DCPH

Deciphera

$32.28 /

-0.8 (-2.42%)

, GMAB

Genmab

$42.88 /

-0.16 (-0.37%)

, LPTX

Leap Therapeutics

$2.78 /

+0.125 (+4.72%)

, ORIC

Oric Pharmaceuticals

$24.54 /

-0.67 (-2.66%)

, SYNH

Syneos Health

$93.51 /

-0.83 (-0.88%)

, BGNE

BeiGene

$398.49 /

-5.03 (-1.25%)

, BMY

Bristol-Myers

$60.50 /

-0.82 (-1.34%)

, BYSI

BeyondSpring

$15.37 /

-7.63 (-33.17%)

, CALA

Calithera Biosciences

$2.18 /

-0.07 (-3.11%)

, GILD

Gilead

$70.97 /

-0.64 (-0.89%)

, GH

Guardant Health

$129.18 /

-2.57 (-1.95%)

, LLY

Eli Lilly

$231.74 /

+1.57 (+0.68%)

, IPSEY

Ipsen

$24.03 /

+0.105 (+0.44%)

, EXAS

Exact Sciences

$105.28 /

-2.97 (-2.74%)

, IDYA

Ideaya Biosciences

$26.22 /

-0.68 (-2.53%)

, GSK

GlaxoSmithKline

$38.84 /

-0.1 (-0.26%)

, RHHBY

Roche

$45.57 /

-0.5 (-1.09%)

, REGN

Regeneron

$641.33 /

-10.43 (-1.60%)

, PFE

Pfizer

$44.22 /

+0.325 (+0.74%)

, TAK

Takeda Pharmaceutical

$17.07 /

-0.095 (-0.55%)

, TMO

Thermo Fisher

$589.96 /

-6.64 (-1.11%)

, TCRR

TCR2 Therapeutics

$9.39 /

-0.61 (-6.10%)

, VERU

Veru

$8.45 /

-0.48 (-5.38%)

, VBLT

VBL Therapeutics

$2.23 /

-0.085 (-3.67%)

, VTRS

Viatris

$13.33 /

-0.24 (-1.77%)

, NVS

Novartis

$82.81 /

-0.68 (-0.81%)

ESMO 2021 Virtual…

ESMO 2021 Virtual Congress will be held on September 16-21. Webcast Link

ShowHide Related Items >><<
VTRS Viatris
$13.33 /

-0.24 (-1.77%)

VERU Veru
$8.45 /

-0.48 (-5.38%)

VBLT VBL Therapeutics
$2.23 /

-0.085 (-3.67%)

TMO Thermo Fisher
$589.96 /

-6.64 (-1.11%)

TCRR TCR2 Therapeutics
$9.39 /

-0.61 (-6.10%)

TAK Takeda Pharmaceutical
$17.07 /

-0.095 (-0.55%)

SYNH Syneos Health
$93.51 /

-0.83 (-0.88%)

RHHBY Roche
$45.57 /

-0.5 (-1.09%)

REGN Regeneron
$641.33 /

-10.43 (-1.60%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

ORIC Oric Pharmaceuticals
$24.54 /

-0.67 (-2.66%)

NVS Novartis
$82.81 /

-0.68 (-0.81%)

LPTX Leap Therapeutics
$2.78 /

+0.125 (+4.72%)

LLY Eli Lilly
$231.74 /

+1.57 (+0.68%)

IPSEY Ipsen
$24.03 /

+0.105 (+0.44%)

IDYA Ideaya Biosciences
$26.22 /

-0.68 (-2.53%)

GSK GlaxoSmithKline
$38.84 /

-0.1 (-0.26%)

GMAB Genmab
$42.88 /

-0.16 (-0.37%)

GILD Gilead
$70.97 /

-0.64 (-0.89%)

GH Guardant Health
$129.18 /

-2.57 (-1.95%)

EXAS Exact Sciences
$105.28 /

-2.97 (-2.74%)

DCPH Deciphera
$32.28 /

-0.8 (-2.42%)

CALA Calithera Biosciences
$2.18 /

-0.07 (-3.11%)

BYSI BeyondSpring
$15.37 /

-7.63 (-33.17%)

BMY Bristol-Myers
$60.50 /

-0.82 (-1.34%)

BGNE BeiGene
$398.49 /

-5.03 (-1.25%)

AYLA Ayala Pharmaceuticals
$12.00 /

-0.31 (-2.52%)

ABBV AbbVie
$106.42 /

-1.35 (-1.25%)

ABBV AbbVie
$106.42 /

-1.35 (-1.25%)

09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
AYLA Ayala Pharmaceuticals
$12.00 /

-0.31 (-2.52%)

07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with Buy, $29 target at Ladenburg
07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with a Buy at Ladenburg
12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
DCPH Deciphera
$32.28 /

-0.8 (-2.42%)

08/04/21 H.C. Wainwright
Deciphera price target lowered to $70 from $75 at H.C. Wainwright
05/05/21 Barclays
Deciphera price target lowered to $65 from $70 at Barclays
05/05/21 H.C. Wainwright
Deciphera price target lowered to $75 from $80 at H.C. Wainwright
05/05/21 Piper Sandler
Deciphera price target lowered to $60 from $75 at Piper Sandler
GMAB Genmab
$42.88 /

-0.16 (-0.37%)

09/16/21
Fly Intel: Top five analyst downgrades
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Genmab to Underweight amid high investor expectations
LPTX Leap Therapeutics
$2.78 /

+0.125 (+4.72%)

09/19/21 Piper Sandler
Piper Sandler keeps Overweight on Leap Therapeutics, ups target to $5
09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
ORIC Oric Pharmaceuticals
$24.54 /

-0.67 (-2.66%)

07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy after tumor data at Citi
07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/21 H.C. Wainwright
Oric Pharmaceuticals price target raised to $54 from $52 at H.C. Wainwright
01/25/21 Citi
Oric Pharmaceuticals downgraded to Neutral from Buy at Citi
SYNH Syneos Health
$93.51 /

-0.83 (-0.88%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
BGNE BeiGene
$398.49 /

-5.03 (-1.25%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BMY Bristol-Myers
$60.50 /

-0.82 (-1.34%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BYSI BeyondSpring
$15.37 /

-7.63 (-33.17%)

09/20/21 H.C. Wainwright
BeyondSpring price target lowered to $65 from $100 at H.C. Wainwright
09/08/21 Baird
BeyondSpring initiated with an Outperform at Baird
08/04/21 Evercore ISI
BeyondSpring price target raised to $95 from $30 at Evercore ISI
08/04/21 William Blair
BeyondSpring may have new standard of care in lung cancer, says William Blair
CALA Calithera Biosciences
$2.18 /

-0.07 (-3.11%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
GILD Gilead
$70.97 /

-0.64 (-0.89%)

07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
GH Guardant Health
$129.18 /

-2.57 (-1.95%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
LLY Eli Lilly
$231.74 /

+1.57 (+0.68%)

09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
IPSEY Ipsen
$24.03 /

+0.105 (+0.44%)

08/16/21 Morgan Stanley
Ipsen price target lowered to EUR 88 from EUR 92 at Morgan Stanley
08/03/21 Morgan Stanley
Ipsen price target raised to EUR 92 from EUR 85 at Morgan Stanley
08/02/21 Societe Generale
Ipsen price target raised to EUR 101 from EUR 90 at Societe Generale
07/30/21 Credit Suisse
Ipsen price target raised to EUR 90 from EUR 75 at Credit Suisse
EXAS Exact Sciences
$105.28 /

-2.97 (-2.74%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/15/21 Canaccord
Exact Sciences progress in MRD space a positive, says Canaccord
09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
IDYA Ideaya Biosciences
$26.22 /

-0.68 (-2.53%)

06/03/21 Baird
Ideaya Biosciences assumed with an Outperform at Baird
04/22/21 Roth Capital
Ideaya Biosciences price target raised to $38 from $31 at Roth Capital
04/19/21 H.C. Wainwright
Ideaya Biosciences price target raised to $35 from $29 at H.C. Wainwright
04/16/21 Roth Capital
Ideaya Biosciences price target raised to $31 from $23 at Roth Capital
GSK GlaxoSmithKline
$38.84 /

-0.1 (-0.26%)

09/20/21 UBS
GlaxoSmithKline price target lowered to 1,460 GBp from 1,540 GBp at UBS
08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
RHHBY Roche
$45.57 /

-0.5 (-1.09%)

09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
REGN Regeneron
$641.33 /

-10.43 (-1.60%)

09/15/21 Cantor Fitzgerald
Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
09/15/21 H.C. Wainwright
Regeneron price target raised to $831 from $787 at H.C. Wainwright
09/15/21 Piper Sandler
Regeneron price target raised to $690 from $675 at Piper Sandler
09/09/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$44.22 /

+0.325 (+0.74%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
TAK Takeda Pharmaceutical
$17.07 /

-0.095 (-0.55%)

09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
TMO Thermo Fisher
$589.96 /

-6.64 (-1.11%)

09/20/21 SVB Leerink
Thermo Fisher price target raised to $675 from $600 at SVB Leerink
09/20/21 JPMorgan
Thermo Fisher price target raised to $700 from $600 at JPMorgan
09/20/21 KeyBanc
Thermo Fisher price target raised to $710 from $555 at KeyBanc
09/20/21 Citi
Thermo Fisher price target raised to $620 from $535 at Citi
TCRR TCR2 Therapeutics
$9.39 /

-0.61 (-6.10%)

09/20/21 Truist
TCR2 Therapeutics price target lowered to $29 from $40 at Truist
09/20/21 H.C. Wainwright
TCR2 Therapeutics price target lowered to $25 from $37 at H.C. Wainwright
09/17/21 Wedbush
TCR2 Therapeutics downgraded to Neutral from Outperform at Wedbush
08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
VERU Veru
$8.45 /

-0.48 (-5.38%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VBLT VBL Therapeutics
$2.23 /

-0.085 (-3.67%)

08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
06/03/21 Roth Capital
Roth Capital ups VBL Therapeutics target to $7 on OVAL primary endpoint update
05/18/21 Guggenheim
VBL Therapeutics initiated with a Buy at Guggenheim
VTRS Viatris
$13.33 /

-0.24 (-1.77%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
NVS Novartis
$82.81 /

-0.68 (-0.81%)

09/20/21 Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
VTRS Viatris
$13.33 /

-0.24 (-1.77%)

VERU Veru
$8.45 /

-0.48 (-5.38%)

VBLT VBL Therapeutics
$2.23 /

-0.085 (-3.67%)

TMO Thermo Fisher
$589.96 /

-6.64 (-1.11%)

TCRR TCR2 Therapeutics
$9.39 /

-0.61 (-6.10%)

TAK Takeda Pharmaceutical
$17.07 /

-0.095 (-0.55%)

SYNH Syneos Health
$93.51 /

-0.83 (-0.88%)

RHHBY Roche
$45.57 /

-0.5 (-1.09%)

REGN Regeneron
$641.33 /

-10.43 (-1.60%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

ORIC Oric Pharmaceuticals
$24.54 /

-0.67 (-2.66%)

NVS Novartis
$82.81 /

-0.68 (-0.81%)

LPTX Leap Therapeutics
$2.78 /

+0.125 (+4.72%)

LLY Eli Lilly
$231.74 /

+1.57 (+0.68%)

IDYA Ideaya Biosciences
$26.22 /

-0.68 (-2.53%)

GSK GlaxoSmithKline
$38.84 /

-0.1 (-0.26%)

GILD Gilead
$70.97 /

-0.64 (-0.89%)

GH Guardant Health
$129.18 /

-2.57 (-1.95%)

EXAS Exact Sciences
$105.28 /

-2.97 (-2.74%)

DCPH Deciphera
$32.28 /

-0.8 (-2.42%)

CALA Calithera Biosciences
$2.18 /

-0.07 (-3.11%)

BYSI BeyondSpring
$15.37 /

-7.63 (-33.17%)

BMY Bristol-Myers
$60.50 /

-0.82 (-1.34%)

BGNE BeiGene
$398.49 /

-5.03 (-1.25%)

AYLA Ayala Pharmaceuticals
$12.00 /

-0.31 (-2.52%)

ABBV AbbVie
$106.42 /

-1.35 (-1.25%)

  • 08
    Jul
  • 03
    Jun
  • 04
    May
  • 09
    Apr
  • 01
    Mar
  • 18
    Feb
  • 20
    Jan
  • 02
    Dec
  • 02
    Dec
  • 19
    Nov
  • 13
    Nov
  • 07
    Oct
TMO Thermo Fisher
$589.96 /

-6.64 (-1.11%)

TAK Takeda Pharmaceutical
$17.07 /

-0.095 (-0.55%)

SYNH Syneos Health
$93.51 /

-0.83 (-0.88%)

RHHBY Roche
$45.57 /

-0.5 (-1.09%)

REGN Regeneron
$641.33 /

-10.43 (-1.60%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

NVS Novartis
$82.81 /

-0.68 (-0.81%)

LLY Eli Lilly
$231.74 /

+1.57 (+0.68%)

GSK GlaxoSmithKline
$38.84 /

-0.1 (-0.26%)

GILD Gilead
$70.97 /

-0.64 (-0.89%)

EXAS Exact Sciences
$105.28 /

-2.97 (-2.74%)

BMY Bristol-Myers
$60.50 /

-0.82 (-1.34%)

BGNE BeiGene
$398.49 /

-5.03 (-1.25%)

ABBV AbbVie
$106.42 /

-1.35 (-1.25%)

VERU Veru
$8.45 /

-0.48 (-5.38%)

TMO Thermo Fisher
$589.96 /

-6.64 (-1.11%)

TAK Takeda Pharmaceutical
$17.07 /

-0.095 (-0.55%)

RHHBY Roche
$45.57 /

-0.5 (-1.09%)

REGN Regeneron
$641.33 /

-10.43 (-1.60%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

ORIC Oric Pharmaceuticals
$24.54 /

-0.67 (-2.66%)

NVS Novartis
$82.81 /

-0.68 (-0.81%)

LPTX Leap Therapeutics
$2.78 /

+0.125 (+4.72%)

LLY Eli Lilly
$231.74 /

+1.57 (+0.68%)

IDYA Ideaya Biosciences
$26.22 /

-0.68 (-2.53%)

GSK GlaxoSmithKline
$38.84 /

-0.1 (-0.26%)

GMAB Genmab
$42.88 /

-0.16 (-0.37%)

GILD Gilead
$70.97 /

-0.64 (-0.89%)

GH Guardant Health
$129.18 /

-2.57 (-1.95%)

EXAS Exact Sciences
$105.28 /

-2.97 (-2.74%)

BYSI BeyondSpring
$15.37 /

-7.63 (-33.17%)

BMY Bristol-Myers
$60.50 /

-0.82 (-1.34%)

BGNE BeiGene
$398.49 /

-5.03 (-1.25%)

ABBV AbbVie
$106.42 /

-1.35 (-1.25%)

VTRS Viatris
$13.33 /

-0.24 (-1.77%)

VERU Veru
$8.45 /

-0.48 (-5.38%)

TMO Thermo Fisher
$589.96 /

-6.64 (-1.11%)

TAK Takeda Pharmaceutical
$17.07 /

-0.095 (-0.55%)

REGN Regeneron
$641.33 /

-10.43 (-1.60%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

LLY Eli Lilly
$231.74 /

+1.57 (+0.68%)

GSK GlaxoSmithKline
$38.84 /

-0.1 (-0.26%)

GILD Gilead
$70.97 /

-0.64 (-0.89%)

BYSI BeyondSpring
$15.37 /

-7.63 (-33.17%)

BMY Bristol-Myers
$60.50 /

-0.82 (-1.34%)

ABBV AbbVie
$106.42 /

-1.35 (-1.25%)

Conference/Events
European Society for Medical Oncology to hold a virtual meeting » 04:55
09/20/21
09/20
04:55
09/20/21
04:55
ABBV

AbbVie

$107.75 /

-0.33 (-0.31%)

, AYLA

Ayala Pharmaceuticals

$12.25 /

-0.01 (-0.08%)

, DCPH

Deciphera

$33.08 /

+1.45 (+4.58%)

, GMAB

Genmab

$43.10 /

+0.845 (+2.00%)

, LPTX

Leap Therapeutics

$2.65 /

+0.13 (+5.16%)

, ORIC

Oric Pharmaceuticals

$25.20 /

+0.99 (+4.09%)

, SYNH

Syneos Health

$94.34 /

+0.55 (+0.59%)

, BGNE

BeiGene

$403.60 /

+18.32 (+4.75%)

, BMY

Bristol-Myers

$61.32 /

+0.1 (+0.16%)

, BYSI

BeyondSpring

$23.00 /

+0.47 (+2.09%)

, CALA

Calithera Biosciences

$2.25 /

+0.2 (+9.76%)

, GILD

Gilead

$71.61 /

+0.34 (+0.48%)

, GH

Guardant Health

$132.01 /

+5.01 (+3.94%)

, LLY

Eli Lilly

$230.17 /

-0.78 (-0.34%)

, IPSEY

Ipsen

$23.92 /

-0.395 (-1.62%)

, EXAS

Exact Sciences

$108.29 /

+5.47 (+5.32%)

, IDYA

Ideaya Biosciences

$26.90 /

+0.9 (+3.46%)

, GSK

GlaxoSmithKline

$38.94 /

-0.16 (-0.41%)

, RHHBY

Roche

$46.07 /

-0.75 (-1.60%)

, REGN

Regeneron

$651.38 /

-2.3 (-0.35%)

, PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

, TAK

Takeda Pharmaceutical

$17.16 /

-0.045 (-0.26%)

, TMO

Thermo Fisher

$596.98 /

+36.11 (+6.44%)

, TCRR

TCR2 Therapeutics

$10.00 /

-5.715 (-36.38%)

, VERU

Veru

$8.94 /

+0.17 (+1.94%)

, VBLT

VBL Therapeutics

$2.32 /

-0.035 (-1.49%)

, VTRS

Viatris

$13.57 /

-0.13 (-0.95%)

, NVS

Novartis

$83.49 /

-0.88 (-1.04%)

ESMO 2021 Virtual…

ESMO 2021 Virtual Congress will be held on September 16-21. Webcast Link

ShowHide Related Items >><<
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IPSEY Ipsen
$23.92 /

-0.395 (-1.62%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GMAB Genmab
$43.10 /

+0.845 (+2.00%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
09/07/21 Morgan Stanley
Morgan Stanley cuts Vertex Pharmaceuticals to Underweight amid AbbVie overhang
AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with Buy, $29 target at Ladenburg
07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with a Buy at Ladenburg
12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

08/04/21 H.C. Wainwright
Deciphera price target lowered to $70 from $75 at H.C. Wainwright
05/05/21 Barclays
Deciphera price target lowered to $65 from $70 at Barclays
05/05/21 H.C. Wainwright
Deciphera price target lowered to $75 from $80 at H.C. Wainwright
05/05/21 Piper Sandler
Deciphera price target lowered to $60 from $75 at Piper Sandler
GMAB Genmab
$43.10 /

+0.845 (+2.00%)

09/16/21
Fly Intel: Top five analyst downgrades
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Genmab to Underweight amid high investor expectations
LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

09/19/21 Piper Sandler
Piper Sandler keeps Overweight on Leap Therapeutics, ups target to $5
09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy after tumor data at Citi
07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/21 H.C. Wainwright
Oric Pharmaceuticals price target raised to $54 from $52 at H.C. Wainwright
01/25/21 Citi
Oric Pharmaceuticals downgraded to Neutral from Buy at Citi
SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

09/08/21 Baird
BeyondSpring initiated with an Outperform at Baird
08/04/21 Evercore ISI
BeyondSpring price target raised to $95 from $30 at Evercore ISI
08/04/21 William Blair
BeyondSpring may have new standard of care in lung cancer, says William Blair
08/04/21 H.C. Wainwright
Wainwright upgrades BeyondSpring with $100 target on lung cancer data
CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
GILD Gilead
$71.61 /

+0.34 (+0.48%)

07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
GH Guardant Health
$132.01 /

+5.01 (+3.94%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
IPSEY Ipsen
$23.92 /

-0.395 (-1.62%)

08/16/21 Morgan Stanley
Ipsen price target lowered to EUR 88 from EUR 92 at Morgan Stanley
08/03/21 Morgan Stanley
Ipsen price target raised to EUR 92 from EUR 85 at Morgan Stanley
08/02/21 Societe Generale
Ipsen price target raised to EUR 101 from EUR 90 at Societe Generale
07/30/21 Credit Suisse
Ipsen price target raised to EUR 90 from EUR 75 at Credit Suisse
EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/15/21 Canaccord
Exact Sciences progress in MRD space a positive, says Canaccord
09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

06/03/21 Baird
Ideaya Biosciences assumed with an Outperform at Baird
04/22/21 Roth Capital
Ideaya Biosciences price target raised to $38 from $31 at Roth Capital
04/19/21 H.C. Wainwright
Ideaya Biosciences price target raised to $35 from $29 at H.C. Wainwright
04/16/21 Roth Capital
Ideaya Biosciences price target raised to $31 from $23 at Roth Capital
GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
08/19/21 Berenberg
GlaxoSmithKline price target raised to 1,625 GBp from 1,570 GBp at Berenberg
RHHBY Roche
$46.07 /

-0.75 (-1.60%)

09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
REGN Regeneron
$651.38 /

-2.3 (-0.35%)

09/15/21 Cantor Fitzgerald
Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
09/15/21 H.C. Wainwright
Regeneron price target raised to $831 from $787 at H.C. Wainwright
09/15/21 Piper Sandler
Regeneron price target raised to $690 from $675 at Piper Sandler
09/09/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

08/04/21 Credit Suisse
Thermo Fisher assumed with an Outperform at Credit Suisse
08/04/21 Argus
Thermo Fisher price target raised to $600 from $530 at Argus
07/29/21 Cowen
Thermo Fisher price target raised to $560 from $525 at Cowen
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

09/17/21 Wedbush
TCR2 Therapeutics downgraded to Neutral from Outperform at Wedbush
08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
VERU Veru
$8.94 /

+0.17 (+1.94%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
06/03/21 Roth Capital
Roth Capital ups VBL Therapeutics target to $7 on OVAL primary endpoint update
05/18/21 Guggenheim
VBL Therapeutics initiated with a Buy at Guggenheim
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
NVS Novartis
$83.49 /

-0.88 (-1.04%)

09/20/21 Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

  • 08
    Jul
  • 03
    Jun
  • 04
    May
  • 09
    Apr
  • 01
    Mar
  • 18
    Feb
  • 20
    Jan
  • 02
    Dec
  • 02
    Dec
  • 19
    Nov
  • 13
    Nov
  • 07
    Oct
TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GMAB Genmab
$43.10 /

+0.845 (+2.00%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

Recommendations
Piper Sandler keeps Overweight on Leap Therapeutics, ups target to $5 » 19:12
09/19/21
09/19
19:12
09/19/21
19:12
LPTX

Leap Therapeutics

$2.65 /

+0.13 (+5.16%)

Piper Sandler analyst…

Piper Sandler analyst Joseph Catanzaro raised the firm's price target on Leap Therapeutics to $5 from $4 and keeps an Overweight rating on the shares after the company held a conference call following data presented at ESMO from the DisTinGuish study in 1st-line G/GEJ cancer that featured two KOLs. Most notably, the KOLs viewed the cohort of patients to actually be enriched for non-responders and that DKN-01 + pembrolizumab maintenance should experience long-term tolerability, the analyst notes. This latter point, together with the waterfall plot could translate to favorable signals of durability, Catanzaro contends. The analyst also points out that additional data are expected in the first half of 2022 and will likely be followed by a database lock later in 2022, which will formally start the clock on BeiGene's Asia option decision.

ShowHide Related Items >><<
LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

Conference/Events
European Society for Medical Oncology to hold a virtual meeting » 04:55
09/19/21
09/19
04:55
09/19/21
04:55
ABBV

AbbVie

$107.75 /

-0.33 (-0.31%)

, AYLA

Ayala Pharmaceuticals

$12.25 /

-0.01 (-0.08%)

, DCPH

Deciphera

$33.08 /

+1.45 (+4.58%)

, GMAB

Genmab

$43.10 /

+0.845 (+2.00%)

, LPTX

Leap Therapeutics

$2.65 /

+0.13 (+5.16%)

, ORIC

Oric Pharmaceuticals

$25.20 /

+0.99 (+4.09%)

, SYNH

Syneos Health

$94.34 /

+0.55 (+0.59%)

, BGNE

BeiGene

$403.60 /

+18.32 (+4.75%)

, BMY

Bristol-Myers

$61.32 /

+0.1 (+0.16%)

, BYSI

BeyondSpring

$23.00 /

+0.47 (+2.09%)

, CALA

Calithera Biosciences

$2.25 /

+0.2 (+9.76%)

, GILD

Gilead

$71.61 /

+0.34 (+0.48%)

, GH

Guardant Health

$132.01 /

+5.01 (+3.94%)

, LLY

Eli Lilly

$230.17 /

-0.78 (-0.34%)

, IPSEY

Ipsen

$23.92 /

-0.395 (-1.62%)

, EXAS

Exact Sciences

$108.29 /

+5.47 (+5.32%)

, IDYA

Ideaya Biosciences

$26.90 /

+0.9 (+3.46%)

, GSK

GlaxoSmithKline

$38.94 /

-0.16 (-0.41%)

, RHHBY

Roche

$46.07 /

-0.75 (-1.60%)

, REGN

Regeneron

$651.38 /

-2.3 (-0.35%)

, PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

, TAK

Takeda Pharmaceutical

$17.16 /

-0.045 (-0.26%)

, TMO

Thermo Fisher

$596.98 /

+36.11 (+6.44%)

, TCRR

TCR2 Therapeutics

$10.00 /

-5.715 (-36.38%)

, VERU

Veru

$8.94 /

+0.17 (+1.94%)

, VBLT

VBL Therapeutics

$2.32 /

-0.035 (-1.49%)

, VTRS

Viatris

$13.57 /

-0.13 (-0.95%)

, NVS

Novartis

$83.49 /

-0.88 (-1.04%)

ESMO 2021 Virtual…

ESMO 2021 Virtual Congress will be held on September 16-21. Webcast Link

ShowHide Related Items >><<
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IPSEY Ipsen
$23.92 /

-0.395 (-1.62%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GMAB Genmab
$43.10 /

+0.845 (+2.00%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
09/07/21 Morgan Stanley
Morgan Stanley cuts Vertex Pharmaceuticals to Underweight amid AbbVie overhang
AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with Buy, $29 target at Ladenburg
07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with a Buy at Ladenburg
12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

08/04/21 H.C. Wainwright
Deciphera price target lowered to $70 from $75 at H.C. Wainwright
05/05/21 Barclays
Deciphera price target lowered to $65 from $70 at Barclays
05/05/21 H.C. Wainwright
Deciphera price target lowered to $75 from $80 at H.C. Wainwright
05/05/21 Piper Sandler
Deciphera price target lowered to $60 from $75 at Piper Sandler
GMAB Genmab
$43.10 /

+0.845 (+2.00%)

09/16/21
Fly Intel: Top five analyst downgrades
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Genmab to Underweight amid high investor expectations
LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy after tumor data at Citi
07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/21 H.C. Wainwright
Oric Pharmaceuticals price target raised to $54 from $52 at H.C. Wainwright
01/25/21 Citi
Oric Pharmaceuticals downgraded to Neutral from Buy at Citi
SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

09/08/21 Baird
BeyondSpring initiated with an Outperform at Baird
08/04/21 Evercore ISI
BeyondSpring price target raised to $95 from $30 at Evercore ISI
08/04/21 William Blair
BeyondSpring may have new standard of care in lung cancer, says William Blair
08/04/21 H.C. Wainwright
Wainwright upgrades BeyondSpring with $100 target on lung cancer data
CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
GILD Gilead
$71.61 /

+0.34 (+0.48%)

07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
GH Guardant Health
$132.01 /

+5.01 (+3.94%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
IPSEY Ipsen
$23.92 /

-0.395 (-1.62%)

08/16/21 Morgan Stanley
Ipsen price target lowered to EUR 88 from EUR 92 at Morgan Stanley
08/03/21 Morgan Stanley
Ipsen price target raised to EUR 92 from EUR 85 at Morgan Stanley
08/02/21 Societe Generale
Ipsen price target raised to EUR 101 from EUR 90 at Societe Generale
07/30/21 Credit Suisse
Ipsen price target raised to EUR 90 from EUR 75 at Credit Suisse
EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/15/21 Canaccord
Exact Sciences progress in MRD space a positive, says Canaccord
09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

06/03/21 Baird
Ideaya Biosciences assumed with an Outperform at Baird
04/22/21 Roth Capital
Ideaya Biosciences price target raised to $38 from $31 at Roth Capital
04/19/21 H.C. Wainwright
Ideaya Biosciences price target raised to $35 from $29 at H.C. Wainwright
04/16/21 Roth Capital
Ideaya Biosciences price target raised to $31 from $23 at Roth Capital
GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
08/19/21 Berenberg
GlaxoSmithKline price target raised to 1,625 GBp from 1,570 GBp at Berenberg
RHHBY Roche
$46.07 /

-0.75 (-1.60%)

09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
REGN Regeneron
$651.38 /

-2.3 (-0.35%)

09/15/21 Cantor Fitzgerald
Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
09/15/21 H.C. Wainwright
Regeneron price target raised to $831 from $787 at H.C. Wainwright
09/15/21 Piper Sandler
Regeneron price target raised to $690 from $675 at Piper Sandler
09/09/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

08/04/21 Credit Suisse
Thermo Fisher assumed with an Outperform at Credit Suisse
08/04/21 Argus
Thermo Fisher price target raised to $600 from $530 at Argus
07/29/21 Cowen
Thermo Fisher price target raised to $560 from $525 at Cowen
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

09/17/21 Wedbush
TCR2 Therapeutics downgraded to Neutral from Outperform at Wedbush
08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
VERU Veru
$8.94 /

+0.17 (+1.94%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
06/03/21 Roth Capital
Roth Capital ups VBL Therapeutics target to $7 on OVAL primary endpoint update
05/18/21 Guggenheim
VBL Therapeutics initiated with a Buy at Guggenheim
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
NVS Novartis
$83.49 /

-0.88 (-1.04%)

09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

  • 08
    Jul
  • 03
    Jun
  • 04
    May
  • 09
    Apr
  • 01
    Mar
  • 18
    Feb
  • 20
    Jan
  • 02
    Dec
  • 02
    Dec
  • 19
    Nov
  • 13
    Nov
  • 07
    Oct
TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GMAB Genmab
$43.10 /

+0.845 (+2.00%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.